IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

RV144 correlates of risk analysis showed that IgG antibodies to gp70V1V2 scaffolds inversely correlated with risk of HIV acquisition. We investigated IgG antibody responses in RV135 and RV132, two ALVAC-HIV prime-boost vaccine trials conducted in Thailand prior to RV144. Both trials used ALVAC-HIV (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Karasavvas, Nicos, Karnasuta, Chitraporn, Savadsuk, Hathairat, Madnote, Sirinan, Inthawong, Dutsadee, Chantakulkij, Somsak, Rittiroongrad, Surawach, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Thongcharoen, Prasert, Siriyanon, Vinai, Andrews, Charla A., Barnett, Susan W., Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, de Souza, Mark S., Paris, Robert M., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2015
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4651018/
https://ncbi.nlm.nih.gov/pubmed/26234467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2015.0034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados